Methyl2-methyl-4-(3-methylthiophen-2-yl)-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylate
98%
- Product Code: 213912
CAS:
879027-86-8
| Molecular Weight: | 339.41 g./mol | Molecular Formula: | C₁₈H₁₇N₃O₂S |
|---|---|---|---|
| EC Number: | MDL Number: | ||
| Melting Point: | Boiling Point: | ||
| Density: | Storage Condition: | Room temperature |
Product Description:
Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of novel anxiolytic and anticonvulsant agents due to its interaction with benzodiazepine receptors. Also explored for its role in enhancing metabolic stability in drug candidates. Employed in structure-activity relationship (SAR) studies to optimize imidazopyrimidine-based therapeutics.
Sizes / Availability / Pricing:
| Size | Availability | Price | Quantity |
|---|---|---|---|
| 100mg | 10-20 days | £850.02 |
+
-
|
| 250mg | 10-20 days | £1,416.09 |
+
-
|
Methyl2-methyl-4-(3-methylthiophen-2-yl)-4,10-dihydrobenzo[4,5]imidazo[1,2-a]pyrimidine-3-carboxylate
Used in pharmaceutical research as a key intermediate in the synthesis of bioactive compounds targeting central nervous system disorders. Shows potential in the development of novel anxiolytic and anticonvulsant agents due to its interaction with benzodiazepine receptors. Also explored for its role in enhancing metabolic stability in drug candidates. Employed in structure-activity relationship (SAR) studies to optimize imidazopyrimidine-based therapeutics.
| Mechanism | - |
| Appearance | - |
| Longevity | - |
| Strength | - |
| Storage | - |
| Shelf Life | - |
| Allergen(s) | - |
| Dosage (Range) | - |
| Recommended Dosage | - |
| Dosage (Per Day) | - |
| Recommended Dosage (Per Day) | - |
| Mix Method | - |
| Heat Resistance | - |
| Stable in pH range | - |
| Solubility | - |
| Product Types | - |
| INCI | - |
Purchase History for
Loading purchase history...
Cart
No products
Subtotal:
£0.00
£0.00
Total :